CDEX's Proxy Statement Call
ROCKVILLE, Md., Nov 17, 2006 (BUSINESS WIRE) -- CDEX Inc. (OTCBB: CEXI)
announced today that it will host a conference call to discuss the Proxy
Statement that was filed with the SEC on Wednesday, November 15, 2006. The call
will be held on Wednesday, November 22, 2006 at 10:30 a.m. EST. The format of
the call will be a five minute overview of the proxy, followed by a 10-15 minute
question-and-answer session. All interested parties are encouraged to listen to
the live conference call.
Conference Call Details: The moderator will begin accepting calls from
participants 10 minutes prior to the start of the call. You will need to
identify yourself and state if you are an investor or a member of the general
public before being connecting into the conference call.
Dial-In:
USA/Canada: 1-866-322-1159
International: 416-640-3404
Conference ID: CDEX Proxy Statement Conference Call
About CDEX Inc.
CDEX Inc. is a technology development company with a current focus on developing
and marketing products using chemical detection and validation technologies. At
present, CDEX is devoting its resources to two distinct areas: (i) and quality
assurance (e.g., validation of prescription medication and detection of
counterfeit or sub-par products for brand protection). ValiMed is one line of
CDEX products for the healthcare market; and (ii) identification of substances
of concern (e.g., illegal drugs for law enforcement in the homeland security
market) CDEX is headquartered in Rockville, Maryland with its research and
development laboratory in Tucson, Arizona. For more information, visit
www.cdex-inc.com.
Any statements made in this press release which contain information that is not
historical are essentially forward-looking. Many forward-looking statements can
be identified by the use of words such as "expects," "plans," "may,"
"anticipates," "believes," "should," "intends," "estimates," and other words of
similar meaning. These statements are subject to risks and uncertainties that
cannot be predicted or quantified and, consequently, actual results may differ
materially from those expressed or implied by such forward-looking statements.
Such risks are detailed from time-to-time in filings with the Securities and
Exchange Commission. There is no obligation to publicly update any
forward-looking statements.
SOURCE: CDEX Inc.
CONTACT: CDEX Inc.
Jerry Blair, 301-881-0080
jblair@cdex-inc.com
|
